Advertisement
U.S. markets open in 2 hours 6 minutes

Alnylam Pharmaceuticals Inc (DUL.BE)

Berlin - Berlin Delayed Price. Currency in EUR
146.60-0.20 (-0.14%)
As of 01:05PM CET. Market open.
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,828,292
1,828,292
1,037,418
844,287
492,853
Cost of Revenue
310,406
310,406
168,817
140,144
78,052
Gross Profit
1,517,886
1,517,886
868,601
704,143
414,801
Operating Expense
1,800,061
1,800,061
1,653,673
1,412,795
1,243,239
Operating Income
-282,175
-282,175
-785,072
-708,652
-828,438
Net Non Operating Interest Income Expense
-25,660
-25,660
-131,160
-141,442
-72,687
Other Income Expense
-125,682
-125,682
-210,761
-2,050
45,525
Pretax Income
-433,517
-433,517
-1,126,993
-852,144
-855,600
Tax Provision
6,725
6,725
4,163
680
2,681
Net Income Common Stockholders
-440,242
-440,242
-1,131,156
-852,824
-858,281
Diluted NI Available to Com Stockholders
-440,242
-440,242
-1,131,156
-852,824
-858,281
Basic EPS
-4.11
-3.52
-9.30
-7.20
-7.46
Diluted EPS
-4.11
-3.52
-9.30
-7.20
-7.46
Basic Average Shares
124,321
124,906
121,689
118,451
114,986
Diluted Average Shares
124,321
124,906
121,689
118,451
114,986
Total Operating Income as Reported
-282,175
-282,175
-785,072
-708,652
-828,438
Rent Expense Supplemental
145,687
145,687
131,967
97,259
-
Total Expenses
2,110,467
2,110,467
1,822,490
1,552,939
1,321,291
Net Income from Continuing & Discontinued Operation
-440,242
-440,242
-1,131,156
-852,824
-858,281
Normalized Income
-354,969
-354,969
-969,556
-865,425
-885,187
Interest Income
95,561
95,561
24,808
1,579
11,809
Interest Expense
121,221
121,221
155,968
143,021
84,496
Net Interest Income
-25,660
-25,660
-131,160
-141,442
-72,687
EBIT
-312,296
-312,296
-971,025
-709,123
-771,104
EBITDA
-215,265
-215,265
-885,475
-619,429
-696,669
Reconciled Cost of Revenue
310,406
310,406
168,817
140,144
78,052
Reconciled Depreciation
97,031
97,031
85,550
89,694
74,435
Net Income from Continuing Operation Net Minority Interest
-440,242
-440,242
-1,131,156
-852,824
-858,281
Total Unusual Items Excluding Goodwill
-107,941
-107,941
-204,557
17,262
36,857
Total Unusual Items
-107,941
-107,941
-204,557
17,262
36,857
Normalized EBITDA
-107,324
-107,324
-680,918
-636,691
-733,526
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-22,668
-22,668
-42,957
4,661
9,951